{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:56:06Z","timestamp":1775044566690,"version":"3.50.1"},"reference-count":49,"publisher":"Informa UK Limited","issue":"4","funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceutica","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2026,4,3]]},"DOI":"10.1080\/17474086.2026.2634278","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:34:52Z","timestamp":1771425292000},"page":"389-395","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Policy approach to optimize multiple myeloma treatment sequencing practices"],"prefix":"10.1080","volume":"19","author":[{"given":"Zsuzsa R\u00e9ka","family":"Pozs\u00e1r","sequence":"first","affiliation":[{"name":"Semmelweis University","place":["Budapest, Hungary"]},{"name":"Semmelweis University","place":["Budapest, Hungary"]},{"name":"Syreon Research Institute","place":["Budapest, Hungary"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sol\u00e8ne","family":"Clavreul","sequence":"additional","affiliation":[{"name":"Myeloma Patients Europe AISBL","place":["Brussels, Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise-Lott","family":"Eriksson","sequence":"additional","affiliation":[{"name":"Myeloma Patients Europe AISBL","place":["Brussels, Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Esp\u00edn","sequence":"additional","affiliation":[{"name":"Andalusian School of Public Health","place":["Granada, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca Maria","family":"Gay","sequence":"additional","affiliation":[{"name":"University of Torino","place":["Turin, Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Theresa","family":"Krauth","sequence":"additional","affiliation":[{"name":"Medical University of Vienna","place":["Vienna, Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Racovita","sequence":"additional","affiliation":[{"name":"Myeloma Patients Europe AISBL","place":["Brussels, Belgium"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Severens","sequence":"additional","affiliation":[{"name":"Severens HTA Consultancy","place":["Heemskerk, Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Entrala Cerezo","sequence":"additional","affiliation":[{"name":"Janssen-Cilag SA","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"Gros Otero","sequence":"additional","affiliation":[{"name":"Janssen-Cilag SA","place":["Madrid, Spain"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tam\u00e1s","family":"\u00c1gh","sequence":"additional","affiliation":[{"name":"Syreon Research Institute","place":["Budapest, Hungary"]},{"name":"University of Pecs","place":["Pecs, Hungary"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n","family":"Kal\u00f3","sequence":"additional","affiliation":[{"name":"Semmelweis University","place":["Budapest, Hungary"]},{"name":"Semmelweis University","place":["Budapest, Hungary"]},{"name":"Syreon Research Institute","place":["Budapest, Hungary"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,2,22]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12091451"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000109"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_432204"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad053"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00535"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X21994553"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009167"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2014.387"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1454"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-6296(02)00126-1"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.2265"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43441-024-00706-6"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2024.2432815"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00432-4"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462320000215"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2025.11.013"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462324004641"},{"key":"e_1_3_5_20_1","unstructured":"Chamova J. Mapping of HTA national organisations programmes and processes in EU and Norway. European commission [Internet]. 2017 [cited 2025 Dec 1]. Available from: https:\/\/health.ec.europa.eu\/document\/download\/18a3dc1d-4876-4553-a292-84fc4a7f9e31_en"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.06.007"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2022.2133823"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_200867"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-07503-y"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.202200"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2021.09.013"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02404-6"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1231720"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.6296"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1215\/03616878-8543262"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.844779"},{"key":"e_1_3_5_32_1","article-title":"The conundrum of clinical trial endpoints in multiple myeloma: we don\u2019t have all the time in the world","author":"Holstein SA","year":"2020","unstructured":"Holstein SA, Suman VJ, Hillengass J, et al. The conundrum of clinical trial endpoints in multiple myeloma: we don\u2019t have all the time in the world. ASCO Dly News [Internet]. 2020 [cited 2025 Dec 1]. Available from: https:\/\/dailynews.ascopubs.org\/do\/conundrum-clinical-trial-endpoints-multiple-myeloma-we-don-t-have-all-time-world","journal-title":"ASCO Dly News"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26166"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.120790"},{"issue":"8","key":"e_1_3_5_35_1","article-title":"Pragmatic clinical trials can play a key role in oncology","volume":"23","author":"Markman M","year":"2022","unstructured":"Markman M. Pragmatic clinical trials can play a key role in oncology. OncLive [Internet]. 2022 [cited 2025 Dec 1];23(8). Available from: https:\/\/www.onclive.com\/view\/pragmatic-clinical-trials-can-play-a-key-role-in-oncology","journal-title":"OncLive"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-024-07935-y"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-189506"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40290-022-00456-6"},{"key":"e_1_3_5_39_1","unstructured":"Rajkumar SV. Order Matters: the art and science of myeloma drug sequencing. ASH clinical news [Internet]. 2017 Apr [cited 2025 Dec 1]. Available from: https:\/\/ashpublications.org\/ashclinicalnews\/news\/3014\/Order-Matters-The-Art-and-Science-of-Myeloma-Drug?searchresult=1"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-025-01041-x"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2022.2144056"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2012.07.008"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.686165"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2021.27.7.936"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/hex.13356"},{"key":"e_1_3_5_46_1","article-title":"Status Update: shared decision-making in hematology","author":"Fairman B","year":"2019","unstructured":"Fairman B. Status Update: shared decision-making in hematology. ASH Clin News [Internet]. 2019; [cited 2025 Dec 1]. Available from: https:\/\/ashpublications.org\/ashclinicalnews\/news\/4802\/Status-Update-Shared-Decision-Making-in-Hematology","journal-title":"ASH Clin News"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1176200"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1177\/1355819618762960"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.12.012"},{"key":"e_1_3_5_50_1","unstructured":"National Pharmaceutical Council [Internet]. Value assessment frameworks. [cited 2025 Dec 1]. Available from: https:\/\/www.npcnow.org\/topics\/value-assessment\/value-assessment-frameworks"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-022-00376-w"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2026.2634278","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:39:21Z","timestamp":1775039961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2026.2634278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,22]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,3]]}},"alternative-id":["10.1080\/17474086.2026.2634278"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2026.2634278","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}